Targeting the muscarinic M1 receptor with a selective, brain-penetrant antagonist to promote remyelination in multiple sclerosis is a research paper published in Proceedings of the National Academy of Sciences (2024). On theSindex it has a DataRank of 0. It has been cited 37 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HHS | NIH | National Institute of Neurological Disorders and Stroke
Grant: R01NS115746
HHS | NIH | National Institute of Mental Health
Grant: R01MH125515
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
Grant: A130141
National Institutes of Health
Grant: 5R01MH125515-04
Cell-type, circuit and network mechanisms of adult oligodendrogenesis in memory storage and retrieval
National Institutes of Health
Grant: 1R01NS115746-01A1
Neuropeptides as axonal determinants for oligodendrocyte differentiation and myelination
FWCI
11.19
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals